TABLE 4.

Characteristics of study population by shedding statusa

CharacteristicNormal (n = 106)Intermittent (n = 24)P
Age (yr [mean ± SD])25.6 ± 7.023.3 ± 6.60.13
No. (%) of subjects
    Gender
        Male73 (69.2)13 (54.2)0.23
        Female33 (30.8)11 (45.8)
    Race
        African American101 (95.3)23 (95.8)1.0
        White5 (4.7)1 (4.2)
Marital status
        Single95 (89.6)22 (91.7)0.87
        Married8 (7.6)2 (8.3)
        Divorced or other3 (2.8)0 (0.0)
    Reason for Visit
        Symptoms75 (70.8)14 (58.3)0.26
        Contact11 (10.4)2 (8.3)
        Positive lab test12 (11.3)3 (12.6)
        Other8 (7.7)5 (20.8)
    Symptoms
        Discharge72 (67.9)13 (54.2)0.06
        Dysuria41 (38.7)12 (50.0)0.05
    STD treated within the last year
        Yes60 (56.6)7 (29.2)0.02
        No46 (43.4)17 (70.8)
    Treatment for gonorrhea within the last year39 (36.8)5 (20.8)0.16
    Other STDs40 (37.7)3 (12.5)
    With the following of partners within the last 6 mo:
        136 (34.0)10 (41.7)0.67
        234 (33.1)5 (20.8)
        3 or more35 (32.9)9 (37.5)
    New partner within the last 30 days
        No76 (71.7)19 (79.2)0.61
        Yes30 (28.3)5 (20.8)
    Treatment at enrollment date
        Ofloxacin101 (95.3)21 (87.5)0.16
        Ceftriaxone1 (1.0)0 (0.0)1.0
        Cefixime4 (3.8)2 (8.3)0.31
No. of days with discharge (mean ± SD)3.9 ± 4.54.0 ± 2.20.92
  • a A total of 130 patients were evaluated.